3.11 Family Planning & Reproductive Options
Key Takeaways
- After genetic risk is identified, standard options include prenatal diagnosis in a spontaneous pregnancy, IVF with PGT, use of donor gametes or embryos, adoption, pursuing pregnancy without genetic testing, and choosing not to have (more) children
- Non-directive counseling presents accurate risks, benefits, limitations, and logistics of each path without steering the patient toward the counselor’s preferred reproductive outcome
- Option selection depends on condition severity/penetrance, inheritance, residual risk, values, religion/culture, finances, timing, and tolerance for uncertainty—not on a single “correct” medical choice
- Donor gametes remove the contribution of the at-risk parental genome for that gamete type but introduce third-party reproduction counseling, identity, and disclosure considerations
- Documenting the decision-making process, offering time-limited follow-up, and revisiting options as life circumstances change are core genetic counseling competencies in Domain 3C
3.11 Family Planning & Reproductive Options
Quick Answer: After risk is identified, families may choose prenatal diagnosis, IVF ± PGT, donor sperm/eggs/embryos, adoption, pregnancy without genetic testing, or not having (additional) children. Counselors present each option’s risk, residual uncertainty, timing, and psychosocial implications in a non-directive frame—supporting informed choice rather than prescribing a single reproductive outcome.
Domain 3C scores whether you can generate a complete option set, tailor it to inheritance and condition facts, and avoid coercive language. Application/analysis items often hinge on what was omitted (e.g., forgetting donor gametes) or on directive slips (“You should do PGT”).
Why Option Counseling Is Its Own Skill
Identifying a pathogenic variant, carrier status, or chromosomal rearrangement answers a medical genetics question; it does not dictate reproduction. Two couples with identical molecular risk may choose opposite paths. Your job is to make each path intelligible and accessible, then support the decision that fits the clients’ goals.
Non-directive does not mean:
- Withholding medical facts or test limitations
- Refusing to correct misconceptions
- Pretending all options are equally available or equally suited to every medical indication
Non-directive does mean:
- Not privileging your personal reproductive values
- Not equating “good patient” with pursuing maximal genetic testing
- Checking understanding and decision consistency with stated values
The Core Reproductive Option Menu
| Option | What it addresses | Key residual issues to name |
|---|---|---|
| Spontaneous conception + prenatal diagnosis (CVS/amnio ± molecular/CMA/karyotype) | Diagnostic information about this pregnancy | Procedure-related risks; timing; possible mosaic/uncertain results; decisions about continuation |
| Spontaneous conception + prenatal screening only (NIPT/serum/ultrasound) | Risk modification, not diagnosis | False positives/negatives; does not replace diagnostic testing for high prior risk monogenic disease |
| IVF with PGT-M/PGT-SR (± PGT-A) | Embryo selection before pregnancy | Cycle failure; mosaic/uninformative results; cost; does not guarantee healthy child; confirmatory prenatal testing may still be offered |
| Donor sperm / donor eggs / donor embryos | Removes at-risk gamete contribution for that parent | Third-party identity, disclosure to child, donor screening limits, legal parentage |
| Adoption (or embryo adoption where available) | Parenting without shared-genome risk from the couple’s gametes | Access, cost, uncertainty of child’s genetics, psychosocial transition |
| Conceive / continue without genetic testing | Autonomy to decline information | Residual recurrence risk unchanged; plan for newborn evaluation if relevant |
| Remain child-free / no further pregnancies | Avoids reproductive genetic risk entirely | Grief, relationship, and identity work—still a valid informed choice |
| Prenatal treatment / specialized fetal therapy (condition-specific, uncommon) | Rare pathways (e.g., certain inborn errors with fetal therapy protocols) | Experimental vs established; center-specific—do not invent availability |
Exam trap: Listing only “test or don’t test” when the vignette asks for reproductive options after a positive carrier screen. Boards expect the full menu, including third-party reproduction and adoption where relevant.
Matching Options to Genetic Context
Autosomal recessive carrier couple
Both partners carry pathogenic variants in the same gene → 25% risk of affected offspring each pregnancy (for fully penetrant childhood disorders). Options commonly discussed: prenatal diagnosis of the familial variants; IVF/PGT-M; donor gamete from a non-carrier (or screened) donor; adoption; untested pregnancy with acceptance of 25% risk; child-free.
Autosomal dominant affected parent
50% transmission risk (adjusted for penetrance/expressivity). Prenatal diagnosis or PGT-M for the known variant; donor gamete from the unaffected partner’s side as applicable (donor egg if maternal AD condition and egg donation chosen, etc.); adoption; decline testing.
X-linked (e.g., female carrier)
Discuss sex-based empiric risks, prenatal diagnosis, PGT-M, and limitations of sex selection alone if the goal is avoiding affected offspring (sex selection without genotype still leaves carrier females and does not address all scenarios).
Balanced translocation carrier
Emphasize empiric risks of miscarriage and unbalanced offspring; PGT-SR; prenatal diagnosis with karyotype/CMA as indicated; donor gametes; adoption.
Uncertain results (VUS, mosaic PGT, inconclusive NIPT)
Option counseling must not treat uncertain genotypes as established diagnoses. Management may focus on phenotype-driven care, additional testing, or proceeding with explicit acknowledgment of uncertainty.
Worked Counseling Scenario
A couple learns they are both carriers for a severe infantile autosomal recessive condition after expanded carrier screening. They want children within two years, have insurance with partial IVF coverage, and state that terminating an affected pregnancy would conflict with their values, but they also fear raising a child with the disorder.
High-yield counseling moves:
- Restate residual risk without testing (25% each pregnancy) and what “affected” means clinically.
- Map options to values: PGT-M aligns with avoiding termination while reducing affected transfers; donor gametes also avoid the 25% risk without prenatal diagnosis decisions; adoption separates parenting from the molecular risk; declining all testing honors autonomy with eyes open.
- Name tradeoffs: PGT requires ART logistics and possible multiple cycles; donor gametes change genetic relatedness; prenatal diagnosis is less useful if termination is unacceptable—though some still want information for preparation.
- Avoid steering: “Given what you shared about termination and about the condition’s severity, families in your situation often compare PGT-M and donor gametes—would you like details on both?” is facilitative; “You should do IVF” is directive.
Psychosocial and Access Layers
Reproductive genetics decisions intersect with:
- Religion and culture (views on embryos, termination, third-party gametes)
- Cost and geography (IVF/PGT access; Medicaid variability)
- Relationship dynamics and blame after carrier results
- Disability perspectives and lived experience of the condition in the family
- Timing (age-related fertility, urgent transplant or oncology fertility preservation contexts)
Offer written summaries, decision aids when available, and follow-up visits. Revisit options after a failed IVF cycle, a miscarriage, or a change in relationship status—preferences are not static.
Documentation and Team Communication
Chart the options reviewed, client understanding, decisions made and deferred, and referrals (REI, prenatal diagnosis clinic, adoption resources, mental health). Coordinate language with reproductive endocrinology and MFM so the family does not hear contradictory “shoulds.”
Master the complete option set plus non-directive application—Domain 3C frequently tests both content completeness and counseling stance.
After both partners are identified as carriers for the same severe autosomal recessive condition, which counseling approach best reflects non-directive reproductive option counseling?
A woman with a known pathogenic autosomal dominant variant asks how donor egg IVF would change reproductive genetic risk compared with using her own eggs. The most accurate statement is:
Which statement correctly distinguishes non-directive counseling from withholding information?
A balanced translocation carrier couple wants children but states they will not terminate a pregnancy under any circumstance. Which option discussion is most appropriately prioritized alongside others?